Rockwell Medical signs product purchase agreement with Concerto

Rockwell Medical announced that the Company signed a three-year product purchase agreement with Concerto Renal Services, the largest provider of dialysis in skilled nursing facilities in the U.S. Under the terms of the agreement, Rockwell Medical will be the primary supplier of liquid and dry acid and bicarbonate concentrates to Concerto through a three-year commitment that includes supply and purchasing minimums. Concerto operates in eleven states – Illinois, Maryland, Kansas, Missouri, Indiana, Michigan, Ohio, Wisconsin, Georgia, Pennsylvania, and Delaware – and is launching operations in several additional states. Founded by nursing home operators who grew frustrated with both the quality of in-house dialysis care and the risks of transporting patients offsite for renal care, Concerto Renal Services began in 2015 with a vision of ‘Giving Life to People on Dialysis’. In the United States, the in-center hemodialysis concentrates market is currently valued at $380M and is anticipated to grow to approximately $500M by 2026, driven primarily by an increasing number of patients suffering from end-stage kidney disease.